Segavin 5 MgTablets
PDF Leaflet Revision Date: 23 August 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Prevention and management of thromboembolic disorders.
Dosage (summary)
Initial: 10-15 mg daily for 3 days; Maintenance: 2.5-10 mg daily.
Onset of Action / Duration
Onset: 24-36 hours, Duration: 2-5 days
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- NSAIDs
- Antibiotics
- Herbal products (St John's Wort)
Contraindications
- Hypersensitivity to warfarin
- Haemorrhagic states
- Pregnancy
- Breastfeeding
Common side effects
- Haemorrhage
- Nausea
- Diarrhoea
- Rash
Counselling Points
- Take at the same time daily
- Avoid NSAIDs
- Report any bleeding symptoms
Serious warnings
- Risk of serious bleeding
- Monitor INR regularly
Important Disclaimer
The Segavin 5 MgTablets professional information leaflet below is the property of Strides Pharma Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
